HeartSciences (HSCS) vs IRIDEX (IRIX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
IRIDEX (IRIX) has outperformed HeartSciences (HSCS) over the past year, losing 17.6% versus a loss of 18.3%. IRIDEX is the larger company by market cap ($15.8 million vs $14.7 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | HSCS | IRIX |
|---|---|---|
| Share price | $3.04 | $0.898 |
| Market cap | $14.73M | $15.77M |
| 1-day change | -12.89% | +2.24% |
| YTD return | -1.62% | -21.23% |
| 1-year return | -18.28% | -17.61% |
| 5-year return | — | -87.88% |
| EPS (TTM) | $-3.21 | $-0.20 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $5.25 | $1.65 |
| 52-week low | $1.63 | $0.61 |
| Distance from 52-week high | -42.10% | -45.58% |
| Analyst consensus | buy | none |
| Avg. price target upside | +294.74% | +206.24% |
| Average volume | 154.08K | 389.24K |
| Shares outstanding | 4.84M | 17.56M |
| Employees | 14 | 93 |
| Sector | Health Care | Health Care |
| Industry | Industrial Specialties | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About HeartSciences
HSCS stock →HeartSciences Inc., a medical technology company, focuses on advancing electrocardiography (ECG) through the integration of artificial intelligence. It develops artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction; MyoVista wavECG device, a resting 12-lead ECG that provides diagnostic information related to cardiac dysfunction, as well as conventional ECG information in the same test; and MyoVista Insights, a cloud-native vendor- and device-agnostic ECG management platform.
Health Care · Industrial Specialties · 14 employees
About IRIDEX
IRIX stock →IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 93 employees
HSCS vs IRIX FAQ
Which is bigger, HeartSciences or IRIDEX?
IRIDEX (IRIX) is larger, with a market capitalization of $15.77M compared with $14.73M for HeartSciences (HSCS).
Which stock has performed better over the past year, HSCS or IRIX?
IRIX returned -17.61% over the past 12 months, compared with -18.28% for HSCS (price return, excluding dividends). Past performance does not predict future results.
Are HeartSciences and IRIDEX in the same industry?
Both are in the Health Care sector, but in different industries: Industrial Specialties for HeartSciences and Biotechnology: Electromedical & Electrotherapeutic Apparatus for IRIDEX.